Showing posts with label Edinburgh Creation Group. Show all posts
Showing posts with label Edinburgh Creation Group. Show all posts

Thursday, February 20, 2014

Darwinism Under the Microscope - Lessons From History · Sylvia Baker




Presented at Edinburgh Creation Group | With the rise of genetics and molecular biology, evidence is emerging that Darwinism is not the unlimited process we once thought.

Sylvia Baker is a biology graduate of the University of Sussex and the University of London. She accepted the evolutionary theory put to her at school and at university - until the pressure of evidence forced her to rethink the whole question.

Downloads

Resolution: 640 x 480 (mp4) | 480 x 320 (MP4) | 320 x 240 (MP4) (right click to download)

Tuesday, December 3, 2013

A Letter to a Pagan City · Phil Holden


A Letter to a Pagan City

Phil Holden - Edinburgh Creation Group
This video shows incredible footage of Edinburgh's Pagan fire festival, which draws over 12,000 people. It also features photos of a government assisted evolution museum that sells books on astrology, tarot, Feng Shui and ghosts. Phil Holden investigates the rise of Paganism in Edinburgh. Edinburgh was at the centre of the Enlightenment movement and was also the city where Charles Darwin was educated. During the Enlightenment in the 18th century, philosophers and scientists agreed that it was unreasonable to consider that God might be a cause of things. Whilst you might expect the result would be a very rational city, it seems the opposite has happened and Edinburgh appears to be one of Europe's most superstitious cities. Whatever your own perspective: Humanist, New Age, Agnostic or religious this video is worth watching.

Downloads

Resolution: 640 x 480 (mp4) | 480 x 320 (MP4) | 320 x 240 (MP4) (right click to download)

Also see The Modern Rise of Paganism by Phil Holden

Tuesday, November 19, 2013

Are We More Than Our DNA? · David Harrison



Are We More Than Our DNA?

David Harrison
To what extent does DNA determine who we are? Prof David Harrison the Director of Cancer Research, University of Edinburgh investigates.

Downloads

Resolution: 480 x 320 (MP4) (right click to download)

Professor David Harrison


David Harrison
Title/Position: John Reid Chair of Pathology (University of St. Andrews), Honorary Chair (University of Edinburgh)
Type of staff member: Associated Principal Investigator
Research Theme: Tissue Remodelling and Regeneration
Research Programme(s): Inflammation and Cancer
Research Group(s): Solid tumour models
Background:


David Harrison has recently joined the University of St Andrews as Professor of Pathology, with an honorary chair at the University of Edinburgh. He is Director of Laboratory Medicine for Lothian NHS, and Designated Individual for Tissue Governance in Lothian. His clinical expertise is in medical liver, kidney and transplant pathology and he contributes to the diagnostic service of the Scottish National Liver Transplant Programme. His research interests are varied, but are based upon understanding how cells and tissue respond to injury. He is Director of the Edinburgh Breakthrough Breast Cancer Research Unit in Edinburgh and has an honorary Professorship in Medicinal Chemistry in the University of Florida. He is also Chair of Medical Research Scotland, Deputy Chair of the Food Standards Agency Committee on Toxicity, trustee of the Melville Trust, board and audit committee member of the Office of the Scottish Charity Regulator, a member of the National Cancer Research Institute Biomarkers & Imaging Clinical Studies Group, member of the Funds Advisory Committee of the Edinburgh & Lothian Health Foundation, board member of the Scottish Life science Association and a member of the European Food Standards Agency Expert Working Group on Aspartame.

Honorary Professor: David Harrison

David Harrison has been made an Honorary Professor in the College of Medicine and Veterinary Medicine.

David HarrisonProfessor Harrison joined the University of St Andrews as Professor of Pathology in May.
He leaves his role as Professor of Pathology in the University of Edinburgh which he has held since 1998.

He is Director of Laboratory Medicine for Lothian NHS, overseeing more than 600 staff working in pathology, genetics, biochemistry and haematology.

He is also Designated Individual for Tissue Governance in Lothian.

Professor Harrison’s clinical expertise is in medical liver, kidney and transplant pathology.
He continues to contribute to the diagnostic service of the Scottish National Liver Transplant Programme, including on-call commitments.

His research interests are varied but based upon understanding how cells and tissue respond to injury. He works with chemists in Edinburgh on hypoxia and mass spectrometry imaging, work that will continue through St Andrews.

He is Director of the Edinburgh Breakthrough Breast Cancer Research Unit, and formerly Director of the Edinburgh Experimental Cancer Medicine Centre.

Professor Harrison has an honorary Professorship in Medicinal Chemistry in the University of Florida where he is part of an award winning distance learning team.

He is chair of Medical Research Scotland, Deputy Chair of the Food Standards Agency Committee on Toxicity, and a member of the European Food Standards Agency Expert Working Group on Aspartame.


Wednesday, October 30, 2013

The Modern Rise of Paganism - Phil Holden




Edinburgh boasts the largest pagan festival in Europe but what is responsible for paganism's modern rise?

Presented at Edinburgh Creation Group

Downloads

Resolution: 640 x 480 (mp4) (right click to download)

Friday, October 25, 2013

Famous Medical Breakthroughs The Christian Pioneers · Dr. Markus Schichtel



Famous Medical Breakthroughs - The Christian Pioneers

Markus Schichtel
Dr Markus Schichtel looks at the lives and work of three famous scientists whose discoveries transformed medical practice. Joseph Lister with antiseptic techniques, James Clerk Maxwell with electrical instruments and James Young Simson an obstetrician and pioneer in the field of anaesthetics.

Downloads

Resolution: 640 x 480 (mp4) | 480 x 320 (MP4) | 320 x 240 (MP4) (right click to download)

Tuesday, September 17, 2013

Let the Rocks Speak - Philip Bell (updated)



Let the Rocks Speak

Philip Bell

Philip Bell looks at the evidence for the Flood from fossils and many features in the rocks that speak of a global catastrophe.
I realized the last 13 minutes of the video got cut off, so the rest is now below:







Philip Bell B.Sc. (Hons.), PGCE, CBiol MSB

Creationist Zoologist, ex-Cancer Researcher and Teacher,
CEO, Creation Ministries International (UK/Europe)

Biography

Philip has a passion to demolish secular and anti-God philosophies through sound biblical exposition and Christian apologetics—drawing from his experience in science, research, education and Christian ministry.
He trusted in Christ as a child and was raised in a strong Christian home to believe the Bible was the inerrant Word of God. However, during his late teens, he compromised with secular, evolutionary ideas about origins. During the course of his later, graduate studies he rejected evolution/millions of years on both scientific and biblical grounds. He came again to see that the Bible is God’s completely trustworthy, infallible Word on scientific and historical matters—as well as on vital matters of Christian faith and conduct.

Education and Professional background:

Philip studied biology and geology at the University of Wales (Swansea) and obtained a BSc (Hons) degree in zoology. Then he spent nine years in cancer research and became an active member of the Postgraduate School of Medicine at Bath University, England. Following this, he obtained a postgraduate teaching qualification (PGCE) from Exeter University and taught school science (and some religious studies) to 11–18 year olds. He continued to publish occasional cancer research papers (in secular medical journals) until 2004 and is a contributor to Creation magazine, Journal of Creation, CMI’s website and other periodicals.

Christian ministry activities:

Since 2001, Philip has traveled throughout the UK, Europe and beyond, teaching and lecturing on Bible/science topics in churches, schools and universities. Up until June 2006, Philip worked for Answers in Genesis in the UK as a speaker/writer and later as Deputy Chief Executive. Currently, he heads up the UK/Europe branch of Creation Ministries International (see creation.com). Philip is married with five children—three grown up and two home-schooled—and is a strong advocate of Christian education.

Education

  • B.Sc. (Hons.) in Zoology, 1989, University of Wales (Swansea). Subsidiaries in geology and botany.
  • P.G.C.E, University of Exeter. Postgraduate Certificate of Education (= Diploma in Education), 1999. Subsidiary course: TEFL (Teaching English as a foreign language).

Awards/Associations

  • C. Biol. M.S.B. Elected member of Institute of Biology and awarded Chartered Biologist status, 1995 (reformed as Society of Biology in October 2009).
  • Member of the School of Postgraduate Medicine, University of Bath, 1995–1998.

Employment Experience

January 2007–present – CEO, Creation Ministries International (UK/Europe).
October 2006–October 2007 – Part-time church worker; regular pastoral and preaching duties in his local church.
2001–2006 – Speaker and writer, later Deputy Chief Executive for Answers in Genesis UK/Europe, Leicester, UK.
1999–2001 – Full time teacher of science (principally biology) in state secondary schools.
1998–1999 – Teacher training
1989–1998 – Clinical scientist involved in cancer, leukaemia and lymphoma research; details below:
Philip gained extensive experience in cell culture techniques, new drug screening, routine light microscopy of all cancers, lymphomas and leukaemias, investigating cytotoxic drug resistance and cellular apoptosis. Some highlights:
1990–1994—A strong work focus was the research and development of new assay techniques. With a colleague, co-developed a novel in vitro technology to aid in micro-cell culture and cytology (OCTOSPOT; now patented and commercially produced), which was funded by two £100,000 S.M.A.R.T. Awards (1992, 1993) from the UK’s Department of Trade and Industry, (see technical abstracts/conference proceedings 7 & 8 below).
1994–1996—primarily involved in research into chronic lymphocytic leukaemia and clinical drug resistance, involving the writing of papers (see technical secular papers 1–4, below). The significance of this work is shown by the fact that papers 1 and 2 are the major support for one arm of the UK MRC (Medical Research Council) 4th National trial of the treatment of CLL (Chronic Lymphocytic Leukaemia; sponsored by Leukaemia Research Fund)—see references 8 and 9 on page 28 of the protocol: <www.icr.ac.uk/research/research_sections/haemato_oncology/4459.pdf.>
1996–1998—Single-handedly designed and conducted a project on drug-resistance in non-Hodgkin’s lymphoma; this was work towards a PhD (done while working full-time) but finished prematurely when funding was curtailed. Philip subsequently left research and retrained as a school teacher. Nevertheless, the first year’s work towards his PhD led him to author two papers (see tech. secular papers 5 and 6), one of which has become the definitive paper on a particular monoclonal antibody to the B-cell receptor CD79a, for distinguishing blood cells of an aggressive, poor-prognosis lymphoma from the very similar cells of the much more indolent chronic lymphocytic leukaemia—widely cited by all immunobiological suppliers of this antibody worldwide, e.g. http://www.acris-antibodies.com/SM1161F.htm, http://www.millipore.com/catalogue/item/cbl538, http://www.antibodies-online.com/antibody/118795/CD79a FITC Human/, http://www.serotec.co.uk/catalog/datasheet-MCA1298.html, http://www.antikoerper-online.de/antibody/118795/CD79a FITC Human/,
This paper is also referenced in the 7th edition (2005) of the standard text Williams Hematology, Chapter 92: Chronic lymphocytic leukaemia and related diseases. It appears as reference no. 297 here (on p. 1373 of the book):
http://books.google.co.uk/books?id=xk3bkH-84lIC&pg=RA3-PA1373&lpg=RA3-PA1373&dq=bell zl7.4&source=web&ots=6FpJaNK3L1&sig=3Uwl0R0iR4HOTglSRW3vhe2xAzw&hl=en&sa=X&oi=book_result&resnum=3&ct=result
Postscript: Philip’s long-standing interest in the uses of co-culturing a cancer patient’s normal and malignant cells in order to establish an ex vivo therapeutic index (see tech. abstracts 4 and 9), led to him co-authoring two major papers on this subject in 2002 and 2004 (see tech. secular papers 7 and 8 below), while working full-time as a creationist speaker and writer.

Publications

Technical articles in secular medical/science journals

Book Chapter
Bosanquet AG & Bell PB. Handling requirements to achieve active drugs in in vitro drug sensitivity and resistance assays. In: Kaspers GJL, Pieters R, Twentyman PR, Weisenthal LM, Veerman AJP (Eds) "Drug resistance in leukemia and lymphoma. The clinical value of laboratory studies." London: Harwood 1993; 227–255.
Papers
  1. Bosanquet AG & Bell PB. Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology. Leukemia Research 1996; 20: 143–153.
  2. Bosanquet AG & Bell PB. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in CLL. Blood 1996; 87: 1962–1971.
  3. Bosanquet AG, Bell PB, Burlton AR, Amos AS. Correlation of bcl-2 with P-glycoprotein expression in chronic lymphocytic leukaemia and other haematological neoplasms but of neither marker with ex vivo chemosensitivity or patient survival. Leukemia and Lymphoma 1996; 24: 141–147.
  4. Bosanquet AG, Burlton AR, Bell PB, Harris AL. Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: results with 8-chloro-cAMP. British Journal of Cancer 1997; 76: 511–518.
  5. Bell PB, Rooney N, Bosanquet AG. CD79a detected by ZL7.4 separating chronic lymphocytic leukemia from mantle cell lymphoma in leukemic phase. Communications in Clinical Cytometry 1999; 38: 102–105.
  6. Bosanquet AG, Bell PB, Rooney N. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse. Anticancer Research 1999; 19: 5329–5334.
  7. Bosanquet AG, Burlton AR, Bell PB. Parameters affecting the ex vivo cytotoxic drug sensitivity of normal human cells. Journal of Experimental Therapeutics and Oncology 2002; 2: 53–63.
  8. Bosanquet AG & Bell PB. Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumour cells: a potential surrogate for patient toxicity and sensitivity. Journal of Experimental Therapeutics and Oncology 2004; 4: 145–154.
Abstracts/Conference Proceedings
  1. Bosanquet AG, Boullier BA, Bell PB, Taylor AR, Betteridge RF. Recent developments in the treatment of leukaemias using the Differential Staining Cytoxicity (DiSC) assay. British Journal of Cancer 1991; 63 (Suppl XIII): 31.
  2. Bosanquet AG, Bell PB, Taylor AR, Chadwick J, Phillips MJ, Johnson SAN. Correlation of clinical response to fludarabine with DiSC assay result. British Journal of Cancer 1991; 64 (Suppl XV): 28.
  3. Bosanquet AG, Taylor AR, Bell PB. Lack of cross resistance between aclarubicin and other anthracyclines: should choice of anthracyclines be made by DiSC assay? British Journal of Cancer 1992; 65 (Suppl XVI): 29.
  4. Bosanquet AG & Bell PB. Variable in vitro therapeutic index found by DiSC assay with fresh human tumour cells. Br J Cancer 1992; 66 (Suppl XVII): 19.
  5. Bosanquet AG, Bell PB, Taylor AR. In vitro DiSC assay results on fresh human cells suggest a trial of amsacrine in chronic lymphocytic leukaemia. Annals of Oncology 1992; 66 (Suppl XVII): 19.
  6. Bosanquet AG, Burlton AR, Bell PB, Talbot D, Harris AL. The in vitro drug sensitivity of 8-chloro-cAMP in leukemia and lymphoma. Br J Cancer 1994; 69: 1187.
  7. Bosanquet AG, Bell PB, Burlton AR, Harris AL, Talbot D. New drug screening by DiSC assay. Technical improvements and results with vinorelbine and 8-chloro-cAMP. Annals of Oncology 1994; 5 (Suppl 5): 78.
  8. Bosanquet AG & Bell PB. New methodology improves the DiSC, MTT and FMC in vitro drug sensitivity assays for determining an individual patient’s drug sensitivity profile. Rev. Invest. Clin. 1994; 272. [see also: Proc. Internat. Soc. Hematol., 1994]
  9. Bosanquet AG, Bell PB, Burlton AR. In vitro therapeutic index of fresh human tumor and normal cells identified by Differential Staining Cytotoxicity (DiSC) assay. Implications for Phase II/III trials. Proceedings of American Association for Cancer Research 1994; 35:368.
  10. Bosanquet AG, Mason JM, Drummond MF, Whiteley G, Bell PB, Burlton AR. Effectiveness and cost-effectiveness of DiSC assay directed therapy in chronic lymphocytic leukaemia. British Journal of Haematology 1994; 186 (Suppl 1): 75.
  11. Bosanquet AG, Amos AS, Bell PB, Burlton AR, Greaves MF. Comparison of BCL-2 and MDR-1 levels in in vitro drug sensitivies by DiSC assay in B-cell and other malignancies. Br. J. Haematol. 1994; 87 (Suppl 1): 83.
  12. Bosanquet AG, Burlton AR, Bell PB, Pleiotropic drug resistance with collateral sensitivity induced by treatment in CLL is unrelated to classical resistance mechanisms, Eg. MDR, GST, MRP. 2nd International Symposium, Drug Resistance in Leukemia and Lymphoma, 1995.
  13. Bosanquet AG, Burlton AR, Bell PB. In vitro radioresponse by DiSC assay of malignant cells using a laboratory cell irradiator. Proceedings of the Röntgen Centenary Congress 1995; 456.
  14. Bosanquet AG, Bell PB, Burlton AR, Whiteley G, Bosanquet MI. Ex vivo drug sensitivity testing aids informed decision making for drug therapy of leukaemia and cancer. Report of: Scientific Basis for Health Services, International Conference, 2–4 October, 1995.
  15. Bosanquet AG, Burlton AR, Bell PB. Ex vivo activity profile of gamma-linolenic acid and cross-resistance with anthracyclines, antimetabolites, alkylators, steroids, vincristine and radiosensitivity. Proceedings of American Association for Cancer Research 1997; 38:104 (#694).

Creation science articles

Selected Creation magazine articles

  1. Mudskippers—marvels of the mud-flats! Creation 34(2):48–50, 2012.
  2. A New Weed Species: Does it prove Creation Wrong? Creation 25(3):27, 2003.
  3. Evolution Revolution, Creation 25(3):31, 2003.
  4. Bishop Bell’s Brass Behemoths! Creation 25(4):40–44, 2003.
  5. Genetic Engineers Unwind Species Barrier. But have they Reversed Evolution? Creation 25(4):52–53, 2003.
  6. Resurrecting a ‘Prehistoric’ horse, Creation 26(2):46–51, 2004.
  7. Horse-shoe Crab Meets ET? Creation 26(4):24–25, 2004.
  8. From Pagan to ‘New Age’ Missionary. Creation 26(4):52–55, 2004.
  9. The Super-Senses of Oilbirds—Bizarre Birds Elude an Evolutionary Explanation, Creation 28(1):38–41, 2005.
  10. ‘Evolutionary Stasis’, Double-speak and Propaganda. Creation 28(2):38–40, 2006.
  11. Surgeon With a Mission: To Make the Evolution Myth Extinct, Creation 29(1):52–55, 2006.
  12. The tale of the hummingbird and the starling, Creation 31(1):20–21, 2009. (Pre-publication version)
  13. Of Snakes, Lizards and Mosasaurs—Evolutionists Puzzle over Snake Origins, Creation 31(3):15–17, 2009.
  14. Snakes: Designed to Kill? Creation 31(4):47, September 2009.
  15. Expert engineer eschews “evolutionary design”, Creation 32 (1):35-37, January 2010.
  16. Rock-solid butter! Creation 33(1):40–41, January 2011.

Selected Journal of Creation (formerly Creation Ex Nihilo Technical Journal and TJ) articles

Image
Papers:
  1. Apoptosis: cell ‘death’ reveals Creation, Journal of Creation 16(1):90–102, 2002.
  2. The Non-evolution of Apoptosis, Journal of Creation 18(1):86–96, 2004.
Perspectives and other articles:
  1. The Portrayal of Creationists by their Evolutionist Detractors, Journal of Creation 16(2):46–53, 2002.
  2. Pattern of Programmed Cell Death in Bat Wing Membrane—Support for Evolution? Journal of Creation 21(1):3–4, 2007.
Book Reviews:
  1. Evolution for Dummies, Journal of Creation 16(1):36–40, 2002. Review of Why Elephants have Big Ears. Understanding the Patterns of Life on Earth, by Chris Lavers (2001).
  2. Contentious Fossils, Journal of Creation 17(2):29–33, 2003. Review of Bone of Contention: Is Evolution True? By Sylvia Baker (2003).
  3. Magnifying Evolutionary Problems, Journal of Creation 18(3):41–45, 2004. Review of Evolution under the Microscope, by David Swift (2002).
  4. Debunking the Molecules-to-man Myth, Journal of Creation 19(3):45–50, 2005. Review of One Small Speck to Man, by Vij Sodera (2003).
  5. Atheist with a Mission, Journal of Creation 21(2):28–34, 2007.
  6. Book review: The magic of reality by Richard Dawkins

Other articles

DVDs

  • Apemen, ‘Missing Links’ & the Bible, CMI
  • Evolution Impossible, CMI
  • The Case for Creation, Vij Sodera Production
  • Battle for the Mind, CMI
  • Design, Death and Suffering, CMI
  • Evolutie? Kijk naar de Feiten! (Dutch; Evolution? Face the Facts!)
  • Het Belang van Genesis in de Godsdienstige Opvoeding (Dutch; The importance of Genesis in the education of faith), Mediagroep in Genesis.
  • Hoe kan ik weten dat God Bestaat? (Dutch; How can I know God exists), MiG.
  • Schepping in Zes Letterlijke Dagen? (Dutch; Creation in Six Literal Days?), MiG.
  • Science, Scripture & the Importance of Worldview in Education and Using Scientific Discoveries to Open Minds and Build Faith (Dutch slides, English speaking), MiG.
  • Waarom de Schepping zo Belangrijk is (Dutch; Why Creation Matters), MiG.
  • Walking with Dinosaurs (Dutch slides), MiG.
  • Zondvloed, Fossielen & Geloof (Dutch; The Flood, Fossils & Faith), MiG.

Thursday, September 12, 2013

Migration after the Flood - Dominic Stratham



Migration after the Flood

Dominic Stratham
Dominic Statham explores how animals and plants spread around the world so quickly after the Flood.

Presented at Edinburgh Creation Group.

Dominic Statham, B.Sc., D.I.S., M.I.E.T., C.Eng.

Biography

Dominic became a Christian as a student in the early eighties. Over the following years, he became convinced of the need to hold firmly to the Bible as the basis for Christian belief and practice. Intrigued by the endless media assertions that “evolution is a fact” and that “the Bible is wrong”, he decided to investigate the scientific issues for himself. He was astonished by the weakness of the arguments presented by evolutionists, and is now keen to help others realise that there is no conflict between science and Christianity, and that the Bible can be trusted from the very first verse.

Dominic has a particular interest in Christian ethics, and his conviction that the Bible is true stems, in part, from his growing appreciation of the wisdom contained in both the Old and New Testaments. These, he has come to realise, perfectly portray the nature of man—his spiritual and moral needs—and provide an understanding of godliness and rightful living that can be found nowhere else. He is convinced that no book is more needed or more relevant in our current age than the Bible.

Dominic is a Chartered Engineer and graduate of Loughborough University in the UK. He has extensive experience of both manufacturing and product development and holds a number of patents. As an employee of Rolls Royce, he worked on projects for the Panavia Tornado and Eurofighter Typhoon and, as an employee of GKN, engineering drivelines for Jaguar and Land Rover vehicles. He is a speaker and writer for CMI-UK/Europe and the author of Evolution: Good Science? Exposing the ideological nature of Darwin’s theory.

Articles


Back to Other biographies and interviews of interest


Tuesday, August 27, 2013

The Eye Designed or Evolved? - Dr. George Marshall



The Eye Designed or Evolved?

Dr. George Marshall
Did the eye evolve from a simple layer of photo-sensitive cells into the eyes that we have today? Darwin remarked that ... "several facts make me suspect that any sensitive nerve may be rendered sensitive to light" ... but how do photo-sensitive cells work? Is the invertebrate eye really wired the wrong way round? Dr George Marshall an expert in anatomy, who specialised in the human eye for several years answers these questions and many more.

Downloads

Resolution: 480 x 320 (MP4) (right click to download)

The following article appeared in Creation Magazine a number of years ago.

An Eye for Creation

An Interview with Eye-Disease Researcher Dr George Marshall, University of Glasgow, Scotland

Featured In

This Issue
Dr George Marshall obtained his B.Sc. (Hons.) in Biology at the University of Strathclyde in 1984. He conducted research into bone marrow cancer at the University of Sheffield for three years until invalided out with a serious, normally incurable illness. He was dramatically healed of this in November 1987 and soon obtained an M.Med.Sci. from Sheffield. He then worked at the University of Manchester before taking up a post at the University of Glasgow in 1988. He obtained his Ph.D. in Ophthalmic Science at Glasgow in 1991 and was elected to chartered biologist (C.Biol.) status and to membership of the Institute of Biology (M.I.Biol.) in 1993. He is now Sir Jules Thorn Lecturer in Ophthalmic Science.

Creation magazine [CM]: Dr Marshall, you wrote to us to comment on the article “Seeing back to front” which appeared in the March–May 1996 issue of Creation magazine. What was your comment?
Dr George Marshall [GM]: I pointed out that the principal reason as to why the eye cannot be regarded as being wired backward (as some evolutionists claim) was hidden in a footnote in your article.

CM: Would you care to elaborate?
Dr George Marshall
Dr George Marshall,
an eye-disease researcher from
the University of Glasgow,
Scotland
GM: The light-detecting structures within photoreceptor cells are located in the stack of discs. These discs are being continually replaced by the formation of new ones at the cell body end of the stack, thereby pushing older discs down the stack. Those discs at the other end of the stack are ‘swallowed’ by a single layer of retinal pigment epithelial (RPE) cells. RPE cells are highly active, and for this they need a very large blood supply—the choroid. Unlike the retina, which is virtually transparent, the choroid is virtually opaque, because of the vast numbers of red blood cells within it. For the retina to be wired the way that Professor Richard Dawkins suggested, would require the choroid to come between the photoreceptor cells and the light, for RPE cells must be kept in intimate contact with both the choroid and photoreceptor to perform their job. Anybody who has had the misfortune of a hemorrhage in front of the retina will testify as to how well red blood cells block out the light.
Then what do you think of the idea that the eye is wired backward?
The notion that the eye was wired backward occurred to me as a 13-year-old when studying eye anatomy in a school science class. It took me two years of lecturing on human eye anatomy to realize why the eye is wired the way it is. The idea that the eye is wired backward comes from a lack of knowledge of eye function and anatomy.
How do you react to the notion that the human eye is the product of evolution?
The more I study the human eye, the harder it is to believe that it evolved. Most people see the miracle of sight. I see a miracle of complexity on viewing things at 100,000 times magnification. It is the perfection of this complexity that causes me to baulk at evolutionary theory.
Can you give our readers some idea of just how complex the eye is?
The retina is probably the most complicated tissue in the whole body. Millions of nerve cells interconnect in a fantastic number of ways to form a miniature ‘brain’. Much of what the photoreceptors ‘see’ is interpreted and processed by the retina long before it enters the brain.
A computer program has allegedly ‘imitated’ the evolution of an eye. Do you accept this?
Those who produced this model would acknowledge that the model is such a gross oversimplification that it cannot be cited as a proof. May I quote a colleague’s reaction [Dr John Hay, B.Sc.(Hons), Ph.D., M.Sc., C.Biol., F.I.Biol.]:
‘Computer simulation of evolutionary processes such as that described have three important flaws. First, the findings imply that the development which is being measured over so many generations is independent of development of other structures which are necessary for function. Second, the changes observed from the simulation are dependent on the original data input which clearly is consequent to human design of the sequences/regions to be worked on and also the program(s) which are used for the simulation. These are not, therefore, random. The third aspect of all this is that there is translation error in such simulations involving computer hardware/software. This can take the form of electronic error in single bits which are coding for a particular digit. Over many loops in this performance, intrinsic error can be magnified considerably. Was the simulation repeated using different PCs etc.? One feels that these three arguments are essential to any computer simulation package of evolutionary processes.
‘My first point indicated that even if there is an eye, it will be useless unless the organism has the neural and/or the mental processes to utilize information perceived by the eye. How can a chance mutation provide this complexity in several different structures? The argument has usually been that there is a plausible intermediate series of eye-designs in living animals, e.g. Euglena has an eyespot; other organisms have a “cup” which acts as a direction finder.
‘However, the organism which defies this evolution is Nautilus. It has a primitive eye with no lens, which is somewhat surprising considering that its close relative, the squid, has one. This organism has (apparently!) been around for millions of years but has never “evolved” a lens despite the fact that it has a retina which would benefit from this simple change.’
What exactly does your work involve?
Lecturing to doctors in medicine who have specialized in ophthalmology and are attempting to gain fellowship with the Royal College of Ophthalmology (FRCOphth). However, my main remit is research into eye diseases using a combination of transmission electron microscopy and immunocytochemistry—a technique that uses antibodies to locate specific proteins such as enzymes.
Do you believe that accepting creation as portrayed in Genesis is essential to your Christian faith?
Yes! On not literally accepting the Genesis account of creation one is left with a major problem—what Scriptures do you accept as true and what Scriptures do you reject as false? Only by accepting the whole of Scripture as the inspired Word of God does one avoid this dilemma. There are Scriptures that are a source of stumbling to the intellect. My practice is to ‘pigeon-hole’ them temporarily and never allow them to be a stumbling block to my faith. It’s amazing how many of these knotty problems have subsequently resolved themselves. Thus Genesis creation may initially appear to be hard to accept, but it strikes me that evolution is equally if not more problematic to believe.
How useful do you find Creation magazine?
Its principal value is that it challenges what is uncritically accepted. Watch any TV program involving nature and you would think that evolution is an established fact. People get bombarded with this so often that they accept it without thinking. Creation magazine makes people realize that it is only a proposal and not fact. There are numerous places in my hospital where I can leave copies on coffee tables to get people to think for themselves.
What advice would you have for Christian students, or for Christians in a science course or teaching situation?
First, recognize that science can become a ‘religion’ in its own right. Scientists say something, so the general public (the ‘worshippers’) accept it without question. Scientists are much more cautious about one another’s findings. Second, science is not static. The science of today is quite different in many ways from the science of yesterday, and will probably bear little resemblance to the science of tomorrow. People once believed in ‘spontaneous generation’ which could be ‘proved’ by putting an old sack and a few bits of cheese in a dark corner. Mice spontaneously generated out of the sack. We laugh at such notions, but I suspect that in a hundred years’ time people will laugh at some of our scientific notions. Third, one can still become an eminent scientist without accepting evolutionary dogma; the ability to produce sound science in the laboratory is not diminished by one’s stance on creation.
Dr Marshall, thank you very much.

Help keep these daily articles coming. Support AiG.

Recommended Resources